Kills 36 Microorganisms in 2 Minutes or Less
A next-generation bleach product that kills C. difficile spores in 2 minutes, has broad surface compatibility for everyday use, and has a low odor that disappears within minutes.
Use Sites and Applications
Medical: Autoclaves, bedrails, bedside tables, carts, counters, computer screens, diagnostic equipment, dialysis machines, glucometers, gurneys, IV pumps, patient monitoring equipment, plastic mattress covers, remote controls, shower fixtures, stretchers, toilet handholds, walls around toilet/patient rooms, wash basins, wheelchairs, x-ray equipment
- Dental: Countertops, dentist chairs, endodontic equipment, instrument trays, light lens covers, operatory surfaces, reception counters/desks
- Veterinary: Animal equipment, transportation vehicles, veterinary care surfaces
- General Use/Miscellaneous surfaces: Bed frames, doorknobs, hand railings, changing tables, highchairs, playpens, bath tubs, sinks and toilets
Directions for Use
- REMOVE gross soil if visible. For C. difficile spores and TB, always clean surface prior to disinfecting.†
- SPRAY 6″–8″ from surface until surface is completely wet.
- To DISINFECT, let stand for 1 minute. To kill C. difficile spores, allow 2 minutes contact.
- WIPE with a clean, damp cloth. Allow to air dry.
CAUTION: Moderate eye irritant. Do not get in eyes or on clothing. Wash thoroughly with soap and water after handling and before eating, drinking, chewing gum, using tobacco, or going to the toilet.
Click on the link below to be redirected to the Clorox Healthcare website:
- Please Contact CLOROX HEALTHCARE with any questions or concerns regarding Clorox products.
NOTE: The C Diff Foundation Does Not Endorse or Promote Any Products Or Services Shared On This Website, This Posting Is Strictly For Information Purposes Only.
“C. diff. Spores and More,” Global Broadcasting Network – innovative and educational interactive healthcare talk radio program discusses
“Xenex Germ Zapping Robots, UV Disinfection Services”
With Our Guest: Dr. Mark Stibich, PhD
Join us as guest, and co-founder of Xenex, Dr. Mark Stibich Epidemiologist and Chief Scientific Officer, discusses UV Disinfection with Xenex UV Disinfecting Systems and Germ Zapping Robots making a clean sweep across the globe zapping C.diff. and all harmful germs that can cause pain, suffering, and double digits in the already stressed healthcare industry.
MORE ABOUT OUR GUEST:
|Dr Mark Stibich, a co-founder of Xenex, Mark oversees scientific research, new technology development, and protocol design. An epidemiologist who has published many scientific papers about Pulsed Xenon technology, Mark is also an inventor on multiple patents. Originally from Dayton, OH, Mark graduated from Yale and the Johns Hopkins University School of Public Health, where he earned a Masters in Health Science and PhD. Mark’s interest in public health has taken him to many distant countries. He served as a Peace Corps health volunteer and then trained Peace Corps health volunteers in Ulaanbaatar, Mongolia. He has conducted research in Russia, Tajikistan, Afghanistan, South Africa, Kenya, the U. S., and Brazil. In addition, he has received grants for and directed HIV/AIDS research and intervention projects throughout Russia and has been a consultant with the USAID project.|
“C. diff. Spores and More ™“ Global Broadcasting Network spotlights world renowned topic experts, research scientists, healthcare professionals, organization representatives,C. diff. survivors, board members, and their volunteers who are all creating positive changes in the
C. diff. community and more.
Through their interviews, the C Diff Foundation mission will connect, educate, and empower many worldwide.
Questions received through the show page portal will be reviewed and addressed by the show’s Medical Correspondent, Dr. Fred Zar, MD, FACP, Dr. Fred Zar is a Professor of Clinical Medicine, Vice Head for Education in the Department of Medicine, and Program Director of the Internal Medicine Residency at the University of Illinois at Chicago. Over the last two decades he has been a pioneer in the study of the treatment of
Clostridium difficile disease and the need to stratify patients by disease severity.
To access the C. diff. Spores and More program page and library, please click on the following link: www.voiceamerica.com/show/2441/c-diff-spores-and-more
Take our show on the go…………..download a mobile app today
Programming for C. diff. Spores and More ™ is made possible through our official Sponsor; Clorox Healthcare